Author:
Mohan Nithyakalyani,Sunder Anusha
Abstract
The pathophysiology of diabetes is related to the levels of insulin within the body, and the body’s ability to utilize insulin. Patients with diabetes persistently go through life-threatening hypoglycaemia. Consequently, their quality of life gets affected, progressively leading them to micro- and macro-vascular complications. This is an unmanageable happening despite the technology advancements in insulin formulations. Nevertheless, islet transplantation is emerging as an alternative therapeutic option. Our chapter will elaborate on the recent advancements in this field highlighting the present-day challenges of clinical islet cell transplantation. Additionally, details about the advancements in cutting-edge clinical research, bio-molecular signaling with special reference to the pre and post transplant, the need for beta-cell replacement therapies, including the application of induced pluripotent stem cells and mesenchymal stem cells are also mentioned in this chapter.
Reference86 articles.
1. de Lapertosa SG, de Moura AF, Decroux C, Duke L, Hammond L, Jacobs E, et al. International Diabetes Federation (IDF). Diabetes Atlas. 9th ed. Brussels, Belgium; 2019. Available from: https://www.diabetesatlas.org/en/. ISBN: 978-2-930229-87-4
2. Peiris H, Park S, Louis S, et al. Discovering human diabetes-risk gene function with genetics and physiological assays. Nature Communications. 2018;9:3855. DOI: 10.1038/s41467-018-06249-3
3. Mohan V, Unnikrishnan R. Precision diabetes: Where do we stand today? The Indian Journal of Medical Research. 2018;148(5):472-475. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6366260/
4. Ragia G, Petridis I, Tavridou A, Christakidis D, Manolopoulos VG. Presence of CYP2C9*3 allele increases risk for hypoglycemia in Type 2 diabetic patients treated with sulfonylureas. Pharmacogenomics. 2009;10(11):1781-1787. Available from: https://www.ncbi.nlm.nih.gov/pubmed/19891554/
5. Dujic T, Zhou K, Tavendale R, Palmer CN, Pearson ER. Effect of serotonin transporter 5-HTTLPR polymorphism on gastrointestinal intolerance to metformin: A GoDARTS study. Diabetes Care. 2016;39(11):1896-1901. DOI: 10.2337/dc16-0706